Thomson Medical Group Ltd.

Thomson Medical Group Ltd.

SSGX:A50
0.05
SGD
0.00
(0.00%)
0.00EPS
1.69BMarket Cap
Feb 05Next Earn
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
Basic EPS, GAAP
-0.01
-0.01
0.01
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.04
0.04
0.12
0.1
0.13
0.13
0.03
0.02
0.02
0.02
0.02
0.02
0.02
- -
Tangible Book Value per Share
0.04
0.04
0.09
0.07
0.01
0.02
0.01
- -
- -
- -
-0.02
-0.01
-0.01
- -
Basic Weighted Avg Shares
887
939
4,255
4,347
4,591
26,041
26,072
26,441
26,441
26,441
26,441
26,441
26,442
26,351
Sales/Revenue/Turnover
1
- -
87
83
103
201
216
240
334
356
351
395
420
230
Operating Margin (%)
-247.58
-2,085.59
3.98
11.75
-7.73
17.2
17.14
20.3
27.51
23.04
13.51
4.03
6.26
16.32
Depreciation Expense
- -
- -
16
6
13
19
17
18
18
21
28
39
41
18
Net Income, GAAP
-5
-6
49
-36
-63
-22
2
14
54
37
14
-48
-30
-2
Effective Tax Rate (%)
- -
- -
3.26
- -
- -
23.06
33.31
35.41
15.46
25.63
37.53
- -
- -
78.57
Profit Margin (%)
-746.72
-2,563.32
56.68
-43.71
-61.37
-11.13
1
5.92
16.11
10.27
4.03
-12.05
-7.07
-0.73
Working Capital
10
16
212
182
-160
-247
148
167
-18
321
25
51
13
- -
LT Debt
- -
- -
- -
120
216
121
342
625
410
744
925
950
918
- -
Total Equity
33
36
501
451
738
737
784
566
608
575
577
548
525
- -
Return on Invested Capital (%)
- -
- -
17.73
- -
- -
2.76
2.12
2.44
6.27
4.66
3
- -
- -
- -
Return on Capital (%)
- -
- -
18.41
- -
- -
-1.87
1
2.1
5.62
4.23
2.79
- -
- -
- -
Return on Common Equity (%)
-15.29
-17.1
18.41
-7.69
-11.82
-3.58
0.32
2.37
10.53
7.09
2.83
-9.8
-6.5
- -

Capital Structure

SGD

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
ST Debt
243
19
- -
LT Borrowings
334
558
- -
LT Finance Leases
19
18
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26,441
26,441
26,441
Market Capitalization
1,692
1,481
1,692

Working Capital

SGD

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
Total Current Assets
292
297
- -
Cash, Cash Equivalents & STI
121
122
- -
Accounts Receivable, Net
24
26
- -
Inventories
147
149
- -
Total Current Liabilities
298
89
- -
Payables & Accruals
- -
- -
- -
ST Debt
243
19
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.52%
-1.36%
-4.18%
Free Cash Flow
-44.72%
35.11%
50.89%
Net Income, GAAP
-0.39%
-57.86%
-37.57%
Sales/Revenue/Turnover
19.58%
12.59%
6.44%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
351
2025
- -
- -
395
2026
- -
- -
420

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Jun Li Heng
Full Time Employees
3,491
Sector
Health services
Industry
Hospital/Nursing management
Address
101 Thomson Road Singapore CE Singapore 307591
IPO Date
Jul 8, 2002
Business
Thomson Medical Group Limited (SGX: A50) is a leading Southeast Asian healthcare provider focused on integrated medical facilities and services, primarily for women and children, with operations in Singapore, Malaysia, and Vietnam. Founded in 1979 and headquartered at 101 Thomson Road, United Square, Singapore, the company operates through segments including hospital services, specialized services, and investment holdings; hospital services encompass obstetrics and gynaecology, paediatrics, diagnostic imaging, pharmacy, 24-hour outpatient care, laboratories, and outpatient clinics at facilities such as the iconic Thomson Medical Centre in Singapore and Thomson Hospital Kota Damansara in Malaysia; specialized services include fertility treatments at TMC Fertility Centre, paediatric centres, cancer care, cardiology, traditional Chinese medicine, specialist dermatology, gynaecological oncology, dentistry, musculoskeletal and sports medicine, medical aesthetics, health screening, orthopaedics, oncology, ophthalmology, and pre-natal diagnostic laboratories; in Vietnam, FV Hospital provides multi-specialty care across over 30 areas including oncology, cardiology, ophthalmology, orthopaedics, maternity, and gastroenterology, with over 200 beds and additional outpatient clinics like FV Saigon Clinic and chiropractic services via ACC. The group also holds a 9.23-hectare freehold waterfront site in Johor Bahru, Malaysia, for the proposed Thomson Iskandar Medical Hub and long-term integrated healthcare city development. In recent developments, the company completed its transformative acquisition of FV Hospital in Vietnam for US$381.4 million on December 21, 2023, marking the largest healthcare M&A in Vietnamese history and expanding its footprint to three key Southeast Asian markets; in August 2025, it announced a S$5.5 billion mega-project in Johor Bahru's Singapore Special Economic Zone, featuring a 500-bed hospital, aged care facilities, assisted living, and a five-star hotel to address regional healthcare demands.